Anaemia (in pregnancy)
ANAEMIA IN PREGNANCY
Over 80-90% of anaemia in pregnancy in the UK is due to iron deficiency.
Definition and diagnostic cut-offs
- in the UK, anaemia in pregnancy is defined as haemoglobin < 110 g/L in the first trimester, < 105 g/L in the second and third trimesters, and < 100 g/L postpartum (1,2)
- World Health Organisation defines anaemia in pregnancy as haemoglobin < 110 g/L across all trimesters (at sea level)
Aetiology and risk factors
- anaemia in pregnancy is more common in patients who are already anaemic or iron-depleted prior to conception
- risk factors include pre-existing menorrhagia, poor dietary intake, short inter-pregnancy interval (< 1 year), high parity, multiple gestation, and inherited haemoglobinopathies (1,4)
Screening and diagnosis
- full blood count should be offered routinely at booking and at 28 weeks gestation, with an additional check at 20-24 weeks for multiple gestations (1,2)
- routine unselected serum ferritin screening is not recommended for all pregnancies (2)
- serum ferritin should be measured early in pregnancy for non-anaemic women at high risk of iron depletion (2)
- serum ferritin < 30 micrograms/L indicates non-anaemic iron deficiency and warrants early oral iron supplementation (2)
- serum ferritin < 15 micrograms/L indicates severe iron depletion (2)
- a microcytic hypochromic blood film should prompt iron-replacement therapy once haemoglobinopathies are excluded (2,4)
Management of iron deficiency anaemia
Oral iron therapy
- first-line treatment for mild iron deficiency anaemia (2)
- modern UK guidelines recommend 65 mg to 100 mg elemental iron daily, such as ferrous fumarate 210 mg once daily or ferrous sulphate 200 mg once daily (2)
- alternate-day dosing or lower daily dosing can be used to improve gastrointestinal tolerance (2)
- oral iron should be taken on an empty stomach with a source of vitamin C, avoiding tea, coffee, dairy, or antacids (2)
- monitoring requires a repeat full blood count at 2-4 weeks, where an adequate response is an increase in haemoglobin of >= 10 g/L (2)
- treatment should continue for 3 months post-correction and at least until 6 weeks postpartum (2)
Parenteral (intravenous) iron
- indicated from the second trimester onwards if there is oral iron intolerance, lack of response to a 2-week oral trial, or late gestation (> 34 weeks) with significant anaemia requiring rapid correction (2)
- systematic review evidence demonstrates that intravenous iron significantly increases maternal haemoglobin and ferritin, increases neonatal ferritin stores, and reduces delivery blood transfusions by 37% (RR 0.63) with an 89% reduction in gastrointestinal adverse events compared to oral iron (3)
Referral and transfusion
- urgent secondary care referral is indicated if haemoglobin < 70 g/L, if severe symptoms are present, or at late gestation (> 34 weeks) (2)
- blood transfusion should be restricted to cases with active bleeding, imminent hemodynamic compromise, or severe symptoms near delivery (2)
Folate deficiency anaemia
- second most common cause of anaemia in pregnancy (1)
- causes macrocytosis which can mask co-existing microcytic iron deficiency (1)
- treated with oral folic acid 5 mg daily (1)
Notes:
- physiological anaemia occurs because plasma volume expands to a greater extent than red cell mass, reducing blood viscosity (1,5)
- lowest perinatal mortality and optimal birth weight are associated with a lowest recorded maternal haemoglobin concentration between 90-110 g/L (9.0-11.0 g/dL) (5,6)
- in well-nourished populations, a fall in haemoglobin to between 90-110 g/L often indicates healthy plasma volume expansion rather than true iron deficiency (5)
Reference:
- National Institute for Health and Care Excellence (NICE). Antenatal care (NICE Guideline NG201). Published August 2021 (Last updated 2024).
- Pavord S, Daru J, Prasannan N, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188(6):819-830.
- Sales SK, Rajprohat S, Simon L, et al. Intravenous vs Oral Iron for Treating Iron Deficiency Anemia in Pregnancy: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2026;9(9):e2630657.
- Barroso F, Allard S, Kahan BC, et al. Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):99-105.
- Little MP, Brocard P, Elliott P, Steer PJ. Hemoglobin concentration in pregnancy and perinatal mortality: a London-based cohort study. Am J Obstet Gynecol. 2005;193(1):220-226.
- Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr. 2000;71(5 Suppl):1285S-1287S.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.